期刊文献+

重度抑郁发作患者一级亲属执行功能测验初步研究 被引量:1

A preliminary study on the executive function in the first degree relatives of the patients with major depression episode
下载PDF
导出
摘要 目的:探讨重度抑郁发作患者一级亲属的执行功能与正常对照组的差异。方法:采用威斯康星分类卡片测验(Wisconsin CardSorting Test,WSCT)对30名重度抑郁发作患者的一级亲属和30名健康对照者的执行功能进行评估。结果:在WSCT测验中,重度抑郁发作患者一级亲属的持续性应答数和持续性错误数、非持续错误数、完成第一个分类所需应答数明显高于正常对照;而正确应答数、概念化水平百分比均明显低于正常对照,差异具有统计学意义。结论:重度抑郁发作患者一级亲属可能存在执行功能受损,尚需进一步更严格的研究证实。 Objective:To test the executive function in the first degree relatives of patients with major depression episode.Methods:The study included 30 relatives of the major depression whose age,sex,and level of education were matched with those of a healthy control group.Wisconsin Card Sorting Test was used to study the executive function.Results: Relatives of major depression episode with scored higher than the control group in terms of the number of preservative response,preservative errors,non preservative errors,trials to complete the first category on the Wisconsin Card Sorting Test,scored lower than the control group in terms of correct response,percent conceptual levels.Conclusions: Executive Functions in first degree relatives of the major depression episode patients was impaired,as compared to that of the healthy controls,this maybe caused by the genetic factor or environmental factors need more study to be confirmed.
机构地区 天津安宁医院
出处 《中国民康医学》 2012年第11期1321-1322,共2页 Medical Journal of Chinese People’s Health
关键词 重度抑郁发作患者 一级亲属 执行功能 Major Depression Episode First Degree Relatives Executive Functions
  • 相关文献

参考文献16

二级参考文献31

共引文献109

同被引文献14

  • 1De Berardis D,Brucchi M,Serroni N,et al.Successful use of agomelatine in the treatment of major depression in a woman taking tamoxifen:a case report[J].Clin Neuropharmacol,2014,37(1):31-33.
  • 2Damiani JM,Sweet BV,Sohoni P.Melatonin:An option for managing sleep disorders in children with autism spectrum disorder[J].Am J Health Syst Pharm,2014,71(2):95-101.
  • 3Srinivasan V,Pandi-Perurnal SR,Trahkt I,et al.Melatonin and melatonergic drugs on sleep:possible mechanisms of action[J].Int J Neurosci,2009,119(6):821-846.
  • 4Smeraldi E,Delmonte D.Agomelatine in depression[J].Expert Opin Drug Saf,2013,12(6):873-880.
  • 5L(o)o H,Hale A,D'haenen H.Determination of the dose of agomelatine,a melatoninergic agonist and selective 5-HT (2C) antagonist,in the treatment of major depressive disorder:a placebo-controlled dose range study[J].Int Clin Psychopharmacol,2002,17 (5):239-247.
  • 6Lejoyeux M,Matharan S,de Bodinat C.How to switch to agomelatine after an unsuccessful try with paroxetine or venlafaxine[J].CNS Spectr,2013,13:1-10.
  • 7Corruble E,de Bodinat C,Belaidi C,et al.Efficacy of agomelatine and escitalopram on depression,subjective sleep and emotional experiences in patients with major depressive disorder:a 24-wk randomized,controlled,double-blind trial[J].Int J Neuropsychopharmaeol,2013,16 (10):2 219-2 234.
  • 8Hickie IB,Rogers NL.Novel melatonin-based therapies:potential advances in the treatment of major depression[J].Lancet,2011,378(9 791):621-631.
  • 9Guaiana G,Gupta S,Chiodo D,et al.Agomelatine versus other antidepressive agents for major depression[J].Cochrane Database Syst Rev,2013,17(12):CD008851.
  • 10Kasper S,Corruble E,Hale A,et al.Antidepressant efficacy of agomelatine versus SSRI/SNRI:results from a pooled analysis of head-to-head studies without a placebo control[J].Int Clin Psychopharmacol,2013,28(1):12-19.

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部